The tissue inhibitors of metalloproteinases (TIMPs): An ancient family with structural and functional diversity
Tóm tắt
Từ khóa
Tài liệu tham khảo
Murphy, 2008, Progress in matrix metalloproteinase research, Mol. Aspects Med., 29, 290, 10.1016/j.mam.2008.05.002
Bauer, 1975, Collagenase production by human skin fibroblasts, Biochem. Biophys. Res. Commun., 64, 232, 10.1016/0006-291X(75)90243-0
Woolley, 1975, Inhibition of human collagenase activity by a small molecular weight serum protein, Biochem. Biophys. Res. Commun., 66, 747, 10.1016/0006-291X(75)90573-2
Kuettner, 1976, Collagenase inhibition by cationic proteins derived from cartilage and aorta, Biochem. Biophys. Res. Commun., 72, 40, 10.1016/0006-291X(76)90957-8
Vater, 1979, Inhibitor of human collagenase from cultures of human tendon, J. Biol. Chem., 254, 3045, 10.1016/S0021-9258(17)30180-1
Welgus, 1979, A specific inhibitor of vertebrate collagenase produced by human skin fibroblasts, J. Biol. Chem., 254, 1938, 10.1016/S0021-9258(17)37747-5
Cawston, 1981, Purification of rabbit bone inhibitor of collagenase, Biochem. J., 195, 159, 10.1042/bj1950159
Nagase, 2008, Tailoring TIMPs for selective metalloproteinase inhibition, 787
Pavloff, 1992, A new inhibitor of metalloproteinases from chicken: ChIMP-3. A third member of the TIMP family, J. Biol. Chem., 267, 17321, 10.1016/S0021-9258(18)41928-X
Brew, 2000, Tissue inhibitors of metalloproteinases: evolution, structure and function, Biochim. Biophys. Acta, Prot. Struct. Mol. Enzymol., 1477, 267, 10.1016/S0167-4838(99)00279-4
Stetefeld, 2001, The laminin-binding domain of agrin is structurally related to N-TIMP-1, Nat. Struct. Biol., 8, 705, 10.1038/90422
Pohar, 1999, Invertebrate tissue inhibitor of metalloproteinase: structure and nested gene organization within the synapsin locus is conserved from Drosophila to human, Genomics, 57, 293, 10.1006/geno.1999.5776
Yu, 2003, Duplication, degeneration and subfunctionalization of the nested synapsin-Timp genes in Fugu, Trends Genet., 19, 180, 10.1016/S0168-9525(03)00048-9
Jaworski, 2007, Potential regulatory relationship between the nested gene DDC8 and its host gene tissue inhibitor of metalloproteinase-2, Physiol. Genomics, 28, 168, 10.1152/physiolgenomics.00160.2006
Williamson, 1990, Disulphide bond assignment in human tissue inhibitor of metalloproteinases (TIMP), Biochem. J., 268, 267, 10.1042/bj2680267
Gomis-Rüth, 1997, Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1, Nature, 389, 77, 10.1038/37995
Murphy, 1991, The N-terminal domain of tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activity [published erratum appears in Biochemistry 1991 Oct 22;30(42):10362], Biochemistry, 30, 8097, 10.1021/bi00247a001
Huang, 1996, Folding and characterization of the amino-terminal domain of human tissue inhibitor of metalloproteinases-1 (TIMP-1) expressed at high yield in E. coli, FEBS Lett., 384, 155, 10.1016/0014-5793(96)00304-3
Amour, 1998, TNF-Alpha converting enzyme (TACE) is inhibited by TIMP-3, FEBS Lett., 435, 39, 10.1016/S0014-5793(98)01031-X
Kashiwagi, 2001, TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5), J. Biol. Chem., 276, 12501, 10.1074/jbc.C000848200
Hamze, 2007, Constraining specificity in the N-domain of tissue inhibitor of metalloproteinases-1; gelatinase-selective inhibitors, Protein Sci., 16, 1905, 10.1110/ps.072978507
Amour, 2000, The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3, FEBS Lett., 473, 275, 10.1016/S0014-5793(00)01528-3
Hashimoto, 2001, Inhibition of ADAMTS4 (aggrecanase-1) by tissue inhibitors of metalloproteinases (TIMP-1, 2, 3 and 4), FEBS Lett., 494, 192, 10.1016/S0014-5793(01)02323-7
Wang, 2006, TIMP-3 inhibits the procollagen N-proteinase ADAMTS-2, Biochem. J., 398, 515, 10.1042/BJ20060630
Jacobsen, 2008, Catalytic properties of ADAM12 and its domain deletion mutants, Biochemistry, 47, 537, 10.1021/bi701629c
Lee, 2005, Total conversion of tissue inhibitor of metalloproteinase (TIMP) for specific metalloproteinase targeting: fine-tuning TIMP-4 for optimal inhibition of tumor necrosis factor-{alpha}-converting enzyme, J. Biol. Chem., 280, 15967, 10.1074/jbc.M500897200
Mochizuki, 2004, ADAM28 is activated by MMP-7 (matrilysin-1) and cleaves insulin-like growth factor binding protein-3, Biochem. Biophys. Res. Commun., 315, 79, 10.1016/j.bbrc.2004.01.022
Black, 2002, Tumor necrosis factor-alpha converting enzyme, Int. J. Biochem. Cell Biol., 34, 1, 10.1016/S1357-2725(01)00097-8
Rocks, 2008, Emerging roles of ADAM and ADAMTS metalloproteinases in cancer, Biochimie, 90, 369, 10.1016/j.biochi.2007.08.008
Murphy, 2008, Reappraising metalloproteinases in rheumatoid arthritis and osteoarthritis: destruction or repair?, Nat. Clin. Pract. Rheumatol., 128, 10.1038/ncprheum0727
Wayne, 2007, TIMP-3 inhibition of ADAMTS-4 (Aggrecanase-1) is regulated by interactions between aggrecan and the C-terminal domain of ADAMTS-4, J. Biol. Chem., 20991, 10.1074/jbc.M610721200
Troeberg, 2008, Calcium pentosan polysulfate is a multifaceted exosite inhibitor of aggrecanases, FASEB J., 22, 3515, 10.1096/fj.08-112680
Rapti, 2008, The isolated N-terminal domains of TIMP-1 and TIMP-3 are insufficient for ADAM10 inhibition, Biochem. J., 411, 433, 10.1042/BJ20071430
Fernandez-Catalan, 1998, Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase a receptor, EMBO J., 17, 5238, 10.1093/emboj/17.17.5238
Tuuttila, 1998, Three-dimensional structure of human tissue inhibitor of metalloproteinases-2 at 2.1Ǻ resolution, J. Mol. Biol., 284, 1133, 10.1006/jmbi.1998.2223
Morgunova, 2002, Structural insight into the complex formation of latent matrix metalloproteinase 2 with tissue inhibitor of metalloproteinase 2, Proc. Natl. Acad. Sci. U. S. A, 99, 7414, 10.1073/pnas.102185399
Iyer, 2007, Crystal structure of the catalytic domain of matrix metalloproteinase-1 in complex with the inhibitory domain of tissue inhibitor of metalloproteinase-1, J. Biol. Chem., 282, 364, 10.1074/jbc.M607625200
Maskos, 2007, Flexibility and variability of TIMP binding: X-ray structure of the complex between collagenase-3/MMP-13 and TIMP-2, J. Mol. Biol., 366, 1222, 10.1016/j.jmb.2006.11.072
Wisniewska, 2008, Structural determinants of the ADAM inhibition by TIMP-3: crystal structure of the TACE-N-TIMP-3 complex, J. Mol. Biol., 381, 1307, 10.1016/j.jmb.2008.06.088
Williamson, 1994, Solution structure of the active domain of tissue inhibitor of metalloproteinases-2. A new member of the OB fold protein family, Biochemistry, 33, 11745, 10.1021/bi00205a010
Muskett, 1998, High resolution structure of the N-terminal domain of tissue inhibitor of metalloproteinases-2 and characterization of its interaction site with matrix metalloproteinase-3, J. Biol. Chem., 273, 21736, 10.1074/jbc.273.34.21736
Wu, 1999, H-1, C-13 and N-15 resonance assignments and secondary structure of the N-terminal domain of human tissue inhibitor of metalloproteinases-1, J. Biomol. NMR, 14, 289, 10.1023/A:1008310807946
Wu, 2000, NMR structure of tissue inhibitor of metalloproteinases-1 implicates localized induced fit in recognition of matrix metalloproteinases, J. Mol. Biol., 295, 257, 10.1006/jmbi.1999.3362
Murzin, 1993, OB(oligonucleotide/oligosaccharide binding)-fold: common structural and functional solution for non-homologous sequences, EMBO J., 12, 861, 10.1002/j.1460-2075.1993.tb05726.x
Hutton, 1998, Kinetic analysis of the mechanism of interaction of full-length TIMP-2 and gelatinase A — evidence for the existence of a low-affinity intermediate, Biochemistry, 37, 10094, 10.1021/bi980616p
Olson, 1997, Kinetic analysis of the binding of human matrix metalloproteinase-2 and -9 to tissue inhibitor of metalloproteinase (TIMP-1 and TIMP-2), J. Biol. Chem., 272, 29975, 10.1074/jbc.272.47.29975
Lee, 2002, The C-terminal domains of TACE weaken the inhibitory action of N-TIMP-3, FEBS Lett., 520, 102, 10.1016/S0014-5793(02)02776-X
Wei, 2005, Reactive site mutations in tissue inhibitor of metalloproteinase-3 disrupt inhibition of matrix metalloproteinases but not tumor necrosis factor-alpha-converting enzyme, J. Biol. Chem., 280, 32877, 10.1074/jbc.C500220200
Itoh, 2001, Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion, EMBO J., 20, 4782, 10.1093/emboj/20.17.4782
Atkinson, 1995, Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes, J. Biol. Chem., 270, 30479, 10.1074/jbc.270.51.30479
Hernandez-Barrantes, 2001, Differential roles of TIMP-4 and TIMP-2 in Pro-MMP-2 activation by MT1-MMP, Biochem. Biophys. Res. Commun., 281, 126, 10.1006/bbrc.2001.4323
Bigg, 2001, Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type I-matrix metalloproteinase, Cancer Res., 61, 3610
English, 2006, Individual Timp deficiencies differentially impact pro-MMP-2 activation, J. Biol. Chem., 281, 10337, 10.1074/jbc.M512009200
Worley, 2003, Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP), Biochem. J., 372, 799, 10.1042/bj20021573
Putnam, 2007, Sea anemone genome reveals ancestral eumetazoan gene repertoire and genomic organization, Science, 317, 86, 10.1126/science.1139158
Huxley-Jones, 2007, The evolution of the vertebrate metzincins; insights from Ciona intestinalis and Danio rerio, BMC. Evol. Biol., 7, 63, 10.1186/1471-2148-7-63
Meng, 1999, Residue 2 of TIMP-1 is a major determinant of affinity and specificity for matrix metalloproteinases but effects of substitutions do not correlate with those of the corresponding P1′ residue of substrate, J. Biol. Chem., 274, 10184, 10.1074/jbc.274.15.10184
Zhan, 2008, Molecular cloning and characterization of Ac-TMP-2, a tissue inhibitor of metalloproteinase secreted by adult Ancylostoma caninum, Mol. Biochem. Parasitol., 162, 142, 10.1016/j.molbiopara.2008.08.008
Montagnani, 2005, The two Cg-timp mRNAs expressed in oyster hemocytes are generated by two gene families and differentially expressed during ontogenesis, Dev. Comp Immunol., 29, 831, 10.1016/j.dci.2005.02.005
Tsukamoto, 2006, Expression of fugu TIMP-3 and -4 genes in adult tissues and embryos, Comp. Biochem. Physiol., B Biochem. Mol. Biol., 144, 395, 10.1016/j.cbpb.2006.04.008
Tsukamoto, 2007, Expression and distribution of fugu TIMP-2s (fgTIMP-2a and fgTIMP-2b) mRNAs in tissues and embryos, Comp. Biochem. Physiol., B Biochem. Mol. Biol., 148, 225, 10.1016/j.cbpb.2007.02.016
Wei, 2003, Drosophila TIMP is a potent inhibitor of MMPs and TACE: similarities in structure and function to TIMP-3, Biochemistry, 42, 12200, 10.1021/bi035358x
Godenschwege, 2000, Inflated wings, tissue autolysis and early death in tissue inhibitor of metalloproteinases mutants of Drosophila, Eur. J. Cell Biol., 79, 495, 10.1078/0171-9335-00072
Bramham, 2005, Functional insights from the structure of the multifunctional C345C domain of C5 of complement, J. Biol. Chem., 280, 10636, 10.1074/jbc.M413126200
Milner, 2005, Matrix metalloproteinase knockout studies and the potential use of matrix metalloproteinase inhibitors in the rheumatic diseases, Curr. Drug Targets. Inflamm. Allergy, 4, 363, 10.2174/1568010054022141
Bode, 1999, Structural properties of matrix metalloproteinases, Cell. Mol. Life Sci., 55, 639, 10.1007/s000180050320
Nagase, 2000, Substrate specificity of MMPs, 39
Lee, 2003, Unveiling the surface epitopes that render tissue inhibitor of metalloproteinase-1 inactive against membrane type 1-matrix metalloproteinase, J. Biol. Chem., 278, 40224, 10.1074/jbc.M305678200
Lee, 2004, Threonine 98, the pivotal residue of tissue inhibitor of metalloproteinases (TIMP)-1 in metalloproteinase recognition, J. Biol. Chem., 279, 17562, 10.1074/jbc.M312589200
Arumugam, 2003, Increased backbone mobility in beta-barrel enhances entropy gain driving binding of N-TIMP-1 to MMP-3, J. Mol. Biol., 327, 719, 10.1016/S0022-2836(03)00180-3
Stetler-Stevenson, 2008, Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities, Sci. Signal., 1, re6, 10.1126/scisignal.127re6
Docherty, 1985, Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity, Nature, 318, 66, 10.1038/318066a0
Gasson, 1985, Molecular characterization and expression of the gene encoding human erythroid-potentiating activity, Nature, 315, 768, 10.1038/315768a0
Bertaux, 1991, Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases, J. Invest. Dermatol., 97, 679, 10.1111/1523-1747.ep12483956
Hayakawa, 1992, Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum, FEBS Lett., 298, 29, 10.1016/0014-5793(92)80015-9
Stetler-Stevenson, 1992, Tissue inhibitor of metalloproteinase-2 (TIMP-2) has erythroid-potentiating activity, FEBS Lett., 296, 231, 10.1016/0014-5793(92)80386-U
Hayakawa, 1994, Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2), J. Cell Sci., 107, 2373, 10.1242/jcs.107.9.2373
Barasch, 1999, Tissue inhibitor of metalloproteinase-2 stimulates mesenchymal growth and regulates epithelial branching during morphogenesis of the rat metanephros, J. Clin. Invest., 103, 1299, 10.1172/JCI4586
Chesler, 1995, Metalloproteinase inhibition and erythroid potentiation are independent activities of tissue inhibitor of metalloproteinases-1, Blood, 86, 4506, 10.1182/blood.V86.12.4506.bloodjournal86124506
Wang, 2002, Both tissue inhibitors of metalloproteinases-1 (TIMP-1) and TIMP-2 activate Ras but through different pathways, Biochem. Biophys. Res. Commun., 296, 201, 10.1016/S0006-291X(02)00741-6
Jung, 2006, Identification of CD63 as a tissue inhibitor of metalloproteinase-1 interacting cell surface protein, EMBO J., 25, 3934, 10.1038/sj.emboj.7601281
Seo, 2003, TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism, Cell, 114, 171, 10.1016/S0092-8674(03)00551-8
D'Alessio, 2008, Tissue inhibitor of metalloproteinases-2 binding to membrane-type 1 matrix metalloproteinase induces MAPK activation and cell growth by a non-proteolytic mechanism, J. Biol. Chem., 283, 87, 10.1074/jbc.M705492200
Taube, 2006, TIMP-1 regulation of cell cycle in human breast epithelial cells via stabilization of p27(KIP1) protein, Oncogene, 25, 3041, 10.1038/sj.onc.1209336
Guedez, 1998, In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1, J. Clin. Invest., 102, 2002, 10.1172/JCI2881
Lambert, 2003, Tissue inhibitor of metalloproteinases-1 signalling pathway leading to erythroid cell survival, Biochem. J., 372, 767, 10.1042/bj20030187
Liu, 2003, Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells against intrinsic apoptotic cell death via the focal adhesion kinase/phosphatidylinositol 3-kinase and MAPK signaling pathway, J. Biol. Chem., 278, 40364, 10.1074/jbc.M302999200
Murphy, 2002, Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis, J. Biol. Chem., 277, 11069, 10.1074/jbc.M111490200
Liu, 2005, Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells from extrinsic cell death: a potential oncogenic activity of tissue inhibitor of metalloproteinase-1, Cancer Res., 65, 898, 10.1158/0008-5472.898.65.3
Kossakowska, 1991, Tissue inhibitor of metalloproteinases-1 (TIMP-1) RNA is expressed at elevated levels in malignant non-Hodgkin's lymphomas, Blood, 77, 2475, 10.1182/blood.V77.11.2475.2475
Zeng, 1995, Elevated tissue inhibitor of metalloproteinase 1 RNA in colorectal cancer stroma correlates with lymph node and distant metastases, Clin. Cancer Res., 1, 899
Holten-Andersen, 2006, Tissue inhibitor of metalloproteinases-1 in the postoperative monitoring of colorectal cancer, Eur. J. Cancer, 42, 1889, 10.1016/j.ejca.2006.01.058
Nakopoulou, 2002, Enhanced mRNA expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in breast carcinomas is correlated with adverse prognosis, J. Pathol., 197, 307, 10.1002/path.1129
Kopitz, 2007, Tissue inhibitor of metalloproteinases-1 promotes liver metastasis by induction of hepatocyte growth factor signaling, Cancer Res., 67, 8615, 10.1158/0008-5472.CAN-07-0232
Guedez, 2001, Tissue inhibitor of metalloproteinases 1 regulation of interleukin-10 in B-cell differentiation and lymphomagenesis, Blood, 97, 1796, 10.1182/blood.V97.6.1796
Guedez, 2005, Tissue inhibitor of metalloproteinase 1 (TIMP-1) promotes plasmablastic differentiation of a Burkitt lymphoma cell line: implications in the pathogenesis of plasmacytic/plasmablastic tumors, Blood, 105, 1660, 10.1182/blood-2004-04-1385
Dasse, 2007, Tissue inhibitor of metalloproteinase-1 promotes hematopoietic differentiation via caspase-3 upstream the MEKK1/MEK6/p38alpha pathway, Leukemia, 21, 595, 10.1038/sj.leu.2404540
Hoegy, 2001, Tissue inhibitor of metalloproteinases-2 (TIMP-2) suppresses TKR-growth factor signaling independent of metalloproteinase inhibition, J. Biol. Chem., 276, 3203, 10.1074/jbc.M008157200
Seo, 2008, TIMP-2 disrupts FGF-2-induced downstream signaling pathways, Microvasc. Res., 76, 145, 10.1016/j.mvr.2008.07.003
Seo, 2006, Shp-1 mediates the antiproliferative activity of tissue inhibitor of metalloproteinase-2 in human microvascular endothelial cells, J. Biol. Chem., 281, 3711, 10.1074/jbc.M509932200
Fager, 2000, Differential spatial distribution and temporal regulation of tissue inhibitor of metalloproteinase mRNA expression during rat central nervous system development, Mech. Dev., 98, 105, 10.1016/S0925-4773(00)00437-8
Perez-Martinez, 2005, Tissue inhibitor of metalloproteinase-2 promotes neuronal differentiation by acting as an anti-mitogenic signal, J. Neurosci., 25, 4917, 10.1523/JNEUROSCI.5066-04.2005
Jaworski, 2006, Tissue inhibitor of metalloproteinase-2 (TIMP-2) expression is regulated by multiple neural differentiation signals, J. Neurochem., 98, 234, 10.1111/j.1471-4159.2006.03855.x
Valente, 1998, TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis, Int. J. Cancer, 75, 246, 10.1002/(SICI)1097-0215(19980119)75:2<246::AID-IJC13>3.0.CO;2-B
Johnson, 2006, Suppression of atherosclerotic plaque progression and instability by tissue inhibitor of metalloproteinase-2: involvement of macrophage migration and apoptosis, Circulation, 113, 2435, 10.1161/CIRCULATIONAHA.106.613281
Lim, 1999, Tissue inhibitor of metalloproteinase-2 induces apoptosis in human T lymphocytes, Ann. N. Y. Acad. Sci., 878, 522, 10.1111/j.1749-6632.1999.tb07715.x
Ahonen, 1998, Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells, Cancer Res., 58, 2310
Bian, 1996, Suppression of in vivo tumor growth and induction of suspension cell death by tissue inhibitor of metalloproteinases (TIMP)-3, Carcinogenesis, 17, 1805, 10.1093/carcin/17.9.1805
Smith, 1997, TIMP-3 induces cell death by stabilizing TNF-alpha receptors on the surface of human colon carcinoma cells, Cytokine, 9, 770, 10.1006/cyto.1997.0233
Baker, 1999, Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3, Br. J. Cancer, 79, 1347, 10.1038/sj.bjc.6690217
Baker, 1998, Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro — TIMP-3 promotes apoptosis, J. Clin. Invest., 101, 1478, 10.1172/JCI1584
Ahonen, 2003, Tissue inhibitor of metalloproteinases-3 induces apoptosis in melanoma cells by stabilization of death receptors, Oncogene, 22, 2121, 10.1038/sj.onc.1206292
Kuettner, 1977, Tumor cell collagenase and its inhibition by a cartilage-derived protease inhibitor, Science, 196, 653, 10.1126/science.193181
Moses, 1990, Identification of an inhibitor of neovascularization from cartilage, Science, 248, 1408, 10.1126/science.1694043
Handsley, 2005, Metalloproteinases and their inhibitors in tumor angiogenesis, Int. J. Cancer, 115, 849, 10.1002/ijc.20945
Feldman, 2004, Modulation of tumor–host interactions, angiogenesis, and tumor growth by tissue inhibitor of metalloproteinase 2 via a novel mechanism, Cancer Res., 64, 4481, 10.1158/0008-5472.CAN-03-2929
Oh, 2001, The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis, Cell, 107, 789, 10.1016/S0092-8674(01)00597-9
Muraguchi, 2007, RECK modulates Notch signaling during cortical neurogenesis by regulating ADAM10 activity, Nat. Neurosci., 10, 838, 10.1038/nn1922
Oh, 2004, Tissue inhibitors of metalloproteinase 2 inhibits endothelial cell migration through increased expression of RECK, Cancer Res., 64, 9062, 10.1158/0008-5472.CAN-04-1981
Oh, 2006, TIMP-2 upregulates RECK expression via dephosphorylation of paxillin tyrosine residues 31 and 118, Oncogene, 25, 4230, 10.1038/sj.onc.1209444
Fernandez, 2003, Structural and functional uncoupling of the enzymatic and angiogenic inhibitory activities of tissue inhibitor of metalloproteinase-2 (TIMP-2): loop 6 is a novel angiogenesis inhibitor, J. Biol. Chem., 278, 40989, 10.1074/jbc.M306176200
Qi, 2003, A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2, Nat. Med., 9, 407, 10.1038/nm846
Kang, 2008, Tissue inhibitor of metalloproteinases-3 interacts with angiotensin II type 2 receptor and additively inhibits angiogenesis, Cardiovasc. Res., 79, 150, 10.1093/cvr/cvn072
Saunders, 2006, Coregulation of vascular tube stabilization by endothelial cell TIMP-2 and pericyte TIMP-3, J. Cell Biol., 175, 179, 10.1083/jcb.200603176
Stratman, 2009, Endothelial cell lumen and vascular guidance tunnel formation requires MT1-MMP-dependent proteolysis in 3-dimensional collagen matrices, Blood, 114, 237, 10.1182/blood-2008-12-196451
Nedivi, 1993, Numerous candidate plasticity-related genes revealed by differential cDNA cloning, Nature, 363, 718, 10.1038/363718a0
Jourquin, 2005, Tissue inhibitor of metalloproteinases-1 (TIMP-1) modulates neuronal death, axonal plasticity, and learning and memory, Eur. J. Neurosci., 22, 2569, 10.1111/j.1460-9568.2005.04426.x
Chaillan, 2006, Involvement of tissue inhibition of metalloproteinases-1 in learning and memory in mice, Behav. Brain Res., 173, 191, 10.1016/j.bbr.2006.06.020
Jaworski, 2005, Prepulse inhibition and fear-potentiated startle are altered in tissue inhibitor of metalloproteinase-2 (TIMP-2) knockout mice, Brain Res., 1051, 81, 10.1016/j.brainres.2005.05.057
Jaworski, 2006, Tissue inhibitor of metalloproteinase-2(TIMP-2)-deficient mice display motor deficits, J. Neurobiol., 66, 82, 10.1002/neu.20205
Roten, 2000, Effects of gene deletion of the tissue inhibitor of the matrix metalloproteinase-type 1 (TIMP-1) on left ventricular geometry and function in mice, J. Mol. Cell. Cardiol., 32, 109, 10.1006/jmcc.1999.1052
Creemers, 2003, Deficiency of TIMP-1 exacerbates LV remodeling after myocardial infarction in mice, Am. J. Physiol, Heart Circ. Physiol., 284, H364, 10.1152/ajpheart.00511.2002
Ikonomidis, 2005, Accelerated LV remodeling after myocardial infarction in TIMP-1-deficient mice: effects of exogenous MMP inhibition, Am. J. Physiol, Heart Circ. Physiol., 288, H149, 10.1152/ajpheart.00370.2004
Mohammed, 2005, Metalloproteinase inhibitor TIMP-1 affects hepatocyte cell cycle via HGF activation in murine liver regeneration, Hepatology, 41, 857, 10.1002/hep.20618
Lee, 2005, Tissue inhibitor of metalloproteinase 1 regulates resistance to infection, Infect. Immun., 73, 661, 10.1128/IAI.73.1.661-665.2005
Wilson, 1999, Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense, Science, 286, 113, 10.1126/science.286.5437.113
Li, 2002, Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury, Cell, 111, 635, 10.1016/S0092-8674(02)01079-6
Lijnen, 2003, Deficiency of tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) impairs nutritionally induced obesity in mice, Thromb. Haemost., 89, 249, 10.1055/s-0037-1613439
Gerin, 2009, Hyperphagia and obesity in female mice lacking tissue inhibitor of metalloproteinase-1, Endocrinology, 150, 1697, 10.1210/en.2008-1409
Lluri, 2008, Tissue inhibitor of metalloproteinase-2 (TIMP-2) regulates myogenesis and beta1 integrin expression in vitro, Exp. Cell Res., 314, 11, 10.1016/j.yexcr.2007.06.007
Lluri, 2006, Tissue inhibitor of metalloproteinase-2 (TIMP-2) regulates neuromuscular junction development via a beta1 integrin-mediated mechanism, J. Neurobiol., 66, 1365, 10.1002/neu.20315
Leco, 2001, Spontaneous air space enlargement in the lungs of mice lacking tissue inhibitor of metalloproteinases-3 (TIMP-3), J. Clin. Invest., 108, 817, 10.1172/JCI200112067
Fata, 2001, Accelerated apoptosis in the Timp-3-deficient mammary gland, J. Clin. Invest., 108, 831, 10.1172/JCI200113171
Fedak, 2004, TIMP-3 deficiency leads to dilated cardiomyopathy, Circulation, 110, 2401, 10.1161/01.CIR.0000134959.83967.2D
Janssen, 2008, Abnormal vessel formation in the choroid of mice lacking tissue inhibitor of metalloprotease-3, Invest. Ophthalmol. Vis. Sci., 49, 2812, 10.1167/iovs.07-1444
Gill, 2003, A null mutation for tissue inhibitor of metalloproteinases-3 (Timp-3) impairs murine bronchiole branching morphogenesis, Dev. Biol., 261, 313, 10.1016/S0012-1606(03)00318-X
Sahebjam, 2007, Increased collagen and aggrecan degradation with age in the joints of Timp3(−/−) mice, Arthritis Rheum., 56, 905, 10.1002/art.22427
Kassiri, 2005, Combination of tumor necrosis factor-alpha ablation and matrix metalloproteinase inhibition prevents heart failure after pressure overload in tissue inhibitor of metalloproteinase-3 knock-out mice, Circ. Res., 97, 380, 10.1161/01.RES.0000178789.16929.cf
Kassiri, 2009, Simultaneous transforming growth factor beta-tumor necrosis factor activation and cross-talk cause aberrant remodeling response and myocardial fibrosis in Timp3-deficient heart, J. Biol. Chem., 284, 29893, 10.1074/jbc.M109.028449
Mohammed, 2004, Abnormal TNF activity in Timp3−/− mice leads to chronic hepatic inflammation and failure of liver regeneration, Nat. Genet., 36, 969, 10.1038/ng1413
Smookler, 2006, Tissue inhibitor of metalloproteinase 3 regulates TNF-dependent systemic inflammation, J. Immunol., 176, 721, 10.4049/jimmunol.176.2.721
Federici, 2005, Timp3 deficiency in insulin receptor-haploinsufficient mice promotes diabetes and vascular inflammation via increased TNF-alpha, J. Clin. Invest., 115, 3494, 10.1172/JCI26052
Fiorentino, 2010, Increased tumor necrosis factor alpha-converting enzyme activity induces insulin resistance and hepatosteatosis in mice, Hepatology, 50, 103, 10.1002/hep.23250
Cruz-Munoz, 2006, TIMP-3 deficiency in the host, but not in the tumor, enhances tumor growth and angiogenesis, Oncogene, 25, 650, 10.1038/sj.onc.1209104
Cruz-Munoz, 2006, Enhanced metastatic dissemination to multiple organs by melanoma and lymphoma cells in timp-3(−/−) mice, Oncogene, 6489, 10.1038/sj.onc.1209663
Weber, 1994, Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy, Nat. Genet., 8, 352, 10.1038/ng1294-352
Li, 2005, TIMP3 mutation in Sorsby's fundus dystrophy: molecular insights, Expert. Rev. Mol. Med., 7, 1, 10.1017/S1462399405010045
Langton, 2000, A novel tissue inhibitor of metalloproteinases-3 mutation reveals a common molecular phenotype in Sorsby's fundus dystrophy, J. Biol. Chem., 275, 27027, 10.1016/S0021-9258(19)61475-4
Tabata, 1998, A novel splice site mutation in the tissue inhibitor of the metalloproteinases-3 gene in Sorsby's fundus dystrophy with unusual clinical features, Hum. Genet., 103, 179
Lin, 2006, A novel His158Arg mutation in TIMP3 causes a late-onset form of Sorsby fundus dystrophy, Am. J. Ophthalmol., 142, 839, 10.1016/j.ajo.2006.06.003
Yeow, 2002, Sorsby's fundus dystrophy tissue inhibitor of metalloproteinases-3 (TIMP-3) mutants have unimpaired matrix metalloproteinase inhibitory activities, but affect cell adhesion to the extracellular matrix, Matrix Biol., 21, 75, 10.1016/S0945-053X(01)00180-9
Langton, 2005, Sorsby's fundus dystrophy mutations impair turnover of TIMP-3 by retinal pigment epithelial cells, Hum. Mol. Genet., 14, 3579, 10.1093/hmg/ddi385
Fogarasi, 2008, Molecular dissection of TIMP3 mutation S156C associated with Sorsby fundus dystrophy, Matrix Biol., 27, 381, 10.1016/j.matbio.2008.01.008
Qi, 2009, S156C mutation in tissue inhibitor of metalloproteinases-3 induces increased angiogenesis, J. Biol. Chem., 284, 19927, 10.1074/jbc.M109.013763
Majid, 2002, Sorsby's fundus dystrophy mutant tissue inhibitors of metalloproteinase-3 induce apoptosis of retinal pigment epithelial and MCF-7 cells, FEBS Lett., 529, 281, 10.1016/S0014-5793(02)03359-8
Majid, 2007, Matrix bound SFD mutant TIMP-3 is more stable than wild type TIMP-3, Br. J. Ophthalmol., 91, 1073, 10.1136/bjo.2006.113225
Kamei, 1999, TIMP-3 in Bruch's membrane: changes during aging and in age-related macular degeneration, Invest. Ophthalmol. Vis. Sci., 40, 2367
Weber, 2002, A mouse model for Sorsby fundus dystrophy, Invest. Ophthalmol. Vis. Sci., 43, 2732
Stone, 1999, A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy, Nat. Genet., 22, 199, 10.1038/9722
Klenotic, 2004, Tissue inhibitor of metalloproteinases-3 (TIMP-3) is a binding partner of EGF-containing fibulin-like extracellular matrix protein 1 (EFEMP1): implications for macular degenerations, J. Biol. Chem., 30469, 10.1074/jbc.M403026200
Roybal, 2005, Aberrant accumulation of fibulin-3 in the endoplasmic reticulum leads to activation of the unfolded protein response and VEGF expression, Invest. Ophthalmol. Vis. Sci., 46, 3973, 10.1167/iovs.05-0070
Troeberg, 2009, The C-terminal domains of ADAMTS-4 and ADAMTS-5 promote association with N-TIMP-3, Matrix Biol., 463, 10.1016/j.matbio.2009.07.005
Emonard, 2004, The low density lipoprotein receptor-related protein mediates endocytic clearance of proMMP-2:TIMP-2 complex through a thrombospondin-independent mechanism, J. Biol. Chem., 54944, 10.1074/jbc.M406792200
Macgregor, 2009, Tissue inhibitor of matrix metalloproteinase-3 levels in the extracellular matrix of lung, kidney, and eye increase with age, J. Histochem. Cytochem., 57, 207, 10.1369/jhc.2008.952531
Pettersen, 2004, UCSF Chimera — a visualization system for exploratory research and analysis, J. Comput. Chem., 25, 1605, 10.1002/jcc.20084
Dereeper, 2008, Phylogeny.fr: robust phylogenetic analysis for the non-specialist, Nucleic Acids Res., 36, W465, 10.1093/nar/gkn180
Nothnick, 1998, Pattern of messenger ribonucleic acid expression of tissue inhibitors of metalloproteinases (TIMPs) during testicular maturation in male mice lacking a functional TIMP-1 gene, Biol. Reprod., 59, 364, 10.1095/biolreprod59.2.364
Nothnick, 2003, Tissue inhibitor of metalloproteinase-1 (TIMP-1) deficient mice display reduced serum progesterone levels during corpus luteum development, Endocrinology, 144, 5, 10.1210/en.2002-220963
Nothnick, 2004, Steroidal regulation of uterine edema and tissue inhibitors of metalloproteinase (TIMP)-3 messenger RNA expression is altered in TIMP-1-deficient mice, Biol. Reprod., 70, 500, 10.1095/biolreprod.103.020834
Nothnick, 2000, Disruption of the tissue inhibitor of metalloproteinase-1 gene results in altered reproductive cyclicity and uterine morphology in reproductive-age female mice, Biol. Reprod., 63, 905, 10.1095/biolreprod63.3.905
Zhou, 2004, Disruption of the TIMP-1 gene product is associated with accelerated endometrial gland formation during early postnatal uterine development, Biol. Reprod., 71, 534, 10.1095/biolreprod.104.029181
Chen, 2006, Tissue inhibitor of metalloproteinase-1 deficiency abrogates obliterative airway disease after heterotopic tracheal transplantation, Am. J. Respir. Cell Mol. Biol., 34, 464, 10.1165/rcmb.2005-0344OC
Kim, 2005, Tissue inhibitor of metalloproteinase-1 deficiency amplifies acute lung injury in bleomycin-exposed mice, Am. J. Respir. Cell Mol. Biol., 33, 271, 10.1165/rcmb.2005-0111OC
Caterina, 2000, Inactivating mutation of the mouse tissue inhibitor of metalloproteinases-2(Timp-2) gene alters proMMP-2 activation, J. Biol. Chem., 275, 26416, 10.1074/jbc.M001271200
Wang, 2000, TIMP-2 is required for efficient activation of proMMP-2 in vivo, J. Biol. Chem., 275, 26411, 10.1074/jbc.M001270200
Tian, 2007, TIMP-3 deficiency accelerates cardiac remodeling after myocardial infarction, J. Mol. Cell Cardiol., 43, 733, 10.1016/j.yjmcc.2007.09.003
Wetzel, 2008, Tissue inhibitor of metalloproteinases-3 facilitates Fas-mediated neuronal cell death following mild ischemia, Cell Death. Differ., 15, 143, 10.1038/sj.cdd.4402246
Mahmoodi, 2005, Lack of tissue inhibitor of metalloproteinases-3 results in an enhanced inflammatory response in antigen-induced arthritis, Am. J. Pathol., 166, 1733, 10.1016/S0002-9440(10)62483-2